STE - STERIS plc

NYSE - NYSE Delayed Price. Currency in USD
114.54
+0.26 (+0.23%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close114.28
Open114.39
Bid0.00 x 800
Ask0.00 x 900
Day's Range114.24 - 115.19
52 Week Range82.88 - 117.48
Volume690,747
Avg. Volume402,060
Market Cap9.692B
Beta1.13
PE Ratio (TTM)40.35
EPS (TTM)2.84
Earnings DateOct 30, 2018 - Nov 5, 2018
Forward Dividend & Yield1.24 (1.14%)
Ex-Dividend Date2018-06-07
1y Target Est125.33
Trade prices are not sourced from all markets
  • STERIS (STE) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
    Zacks5 days ago

    STERIS (STE) Q1 Earnings & Revenues Beat Estimates, Up Y/Y

    STERIS (STE) continues to gain from strength in all business segments in Q1.

  • Associated Press7 days ago

    Steris: Fiscal 1Q Earnings Snapshot

    On a per-share basis, the Derby, Britain-based company said it had net income of 82 cents. Earnings, adjusted for non-recurring costs, came to $1 per share. The results surpassed Wall Street expectations. ...

  • ACCESSWIRE7 days ago

    STERIS plc to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / STERIS plc (NYSE: STE ) will be discussing their earnings results in their Q1 Earnings Call to be held on August 8, 2018 at 10:00 AM Eastern Time. To listen ...

  • See what the IHS Markit Score report has to say about Steris PLC.
    Markit20 days ago

    See what the IHS Markit Score report has to say about Steris PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • GlobeNewswire20 days ago

    STERIS to Announce Fiscal 2019 First Quarter Financial Results on August 8, 2018

    DERBY, U.K.  - July 25, 2018- STERIS plc (STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2019 first quarter financial results at 10:00 a.m. Eastern Time on Wednesday, August 8, 2018.  The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 877-317-6789 in the United States or 1-412-317-6789 internationally, then asking to join the conference call for STERIS plc. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. The referenced conference call and related release may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations.

  • Intuitive Surgical's FDA Approval for SureForm to Aid Surgery
    Zackslast month

    Intuitive Surgical's FDA Approval for SureForm to Aid Surgery

    Intuitive Surgical's (ISRG) SureForm 60 stapler receives FDA approval; strengthens its profile for minimally invasive surgical solutions.

  • MASI or STE: Which Is a Better Investment Option Right Now?
    Zackslast month

    MASI or STE: Which Is a Better Investment Option Right Now?

    Masimo's (MASI) and STERIS' (STE) strong expected growth rates and impressive price performance make them close contenders in the Medical Instruments space.

  • Here's Why You Must Add STERIS (STE) to Your Portfolio Now
    Zacks2 months ago

    Here's Why You Must Add STERIS (STE) to Your Portfolio Now

    STERIS' (STE) acquisition of U.K.-based outsourced sterilization services provider, Synergy Health plc, remains one of its key strategic moves.

  • Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks
    Zacks2 months ago

    Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks

    The suspension of the Medical Device Tax, the evolution of mechatronics and big data in the MedTech space make some of the stocks lucrative picks for investment.

  • GlobeNewswire2 months ago

    Research Report Identifies STERIS plc, Parker-Hannifin, Sturm, Ruger, CoBiz Financial, Black Hills, and Glacier with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, June 22, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STERIS ...

  • Mechatronics for Healthcare: 3 MedTech Stocks to Bet On
    Zacks2 months ago

    Mechatronics for Healthcare: 3 MedTech Stocks to Bet On

    Here we analyze how Medical Mechatronics is creating new opportunities in MedTech for investors who are keen on putting their money in the healthcare space for longer-term gains.

  • Why Is STERIS (STE) Up 5.2% Since Its Last Earnings Report?
    Zacks2 months ago

    Why Is STERIS (STE) Up 5.2% Since Its Last Earnings Report?

    STERIS (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • STERIS (STE) Benefits From Core Business Expansion, Buyouts
    Zacks2 months ago

    STERIS (STE) Benefits From Core Business Expansion, Buyouts

    STERIS' (STE) strong organic growth across specialty services, life sciences and applied sterilization segments raises optimism on the stock.

  • GlobeNewswire2 months ago

    STERIS to Participate in the Goldman Sachs Global Healthcare Conference

    DERBY, U.K.  - June 1, 2018 - STERIS plc (STE) ("STERIS" or the "Company") announced that it will participate in the Goldman Sachs Global Healthcare Conference on Wednesday, June 13, 2018.  Walt Rosebrough, STERIS`s President and CEO, will present at 2:00 p.m. Pacific Time. A simultaneous webcast and replay of the Company`s presentation will be available on STERIS`s investor relations website at www.steris-ir.com. STERIS`s mission is to help our Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe.

  • Is Ashland Overvalued Compared to Its Peers?
    Market Realist2 months ago

    Is Ashland Overvalued Compared to Its Peers?

    As of May 25, Ashland (ASH) was trading at a one-year-forward PE multiple of 21.1x. In comparison, its peer Celanese (CE) was trading at a one-year forward PE multiple of 11.9x. Forward PE is one of the valuation methods that factor in a company’s future earnings estimations.

  • Here's Why STERIS (STE) Stock is a Must Buy at the Moment
    Zacks3 months ago

    Here's Why STERIS (STE) Stock is a Must Buy at the Moment

    STERIS (STE) gains ground on strategic buyouts and divestments.

  • Does STERIS plc’s (NYSE:STE) PE Ratio Signal A Buying Opportunity?
    Simply Wall St.3 months ago

    Does STERIS plc’s (NYSE:STE) PE Ratio Signal A Buying Opportunity?

    STERIS plc (NYSE:STE) is trading with a trailing P/E of 30.2x, which is lower than the industry average of 38.4x. While STE might seem like an attractive stock to buy,Read More...

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of STE earnings conference call or presentation 9-May-18 2:00pm GMT

    Q4 2018 STERIS plc Earnings Call

  • STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
    Zacks3 months ago

    STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y

    Favorable underlying market trends along with a slew of new product and service offerings by STERIS (STE) instill confidence in investors.

  • See what the IHS Markit Score report has to say about Steris PLC.
    Markit3 months ago

    See what the IHS Markit Score report has to say about Steris PLC.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Associated Press3 months ago

    Steris: Fiscal 4Q Earnings Snapshot

    On a per-share basis, the Derby, Britain-based company said it had net income of 86 cents. Earnings, adjusted for non-recurring costs and pretax expenses, were $1.24 per share. The results surpassed Wall ...

  • GlobeNewswire3 months ago

    STERIS Announces Changes to Board of Directors

    John P. Wareham to retire as Chairman and Board member at the Company`s 2018 Annual General Meeting of Shareholders Dr. Mohsen M. Sohi, independent Board member since 2005, expected to be appointed as ...

  • GlobeNewswire3 months ago

    STERIS Announces Financial Results for Fiscal 2018 Fourth Quarter and Full Year

    DERBY, U.K.  - (May 9, 2018) - STERIS plc (STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2018 fourth quarter ended March 31, 2018.  Fiscal 2018 fourth quarter revenue grew 5% to $716.0 million compared with $681.2 million in the fourth quarter of fiscal 2017.  During the fourth quarter, changes in currency added $17.4 million to revenue, which was offset by a $17.0 million negative impact from divestitures.  For the full fiscal year, revenue as reported was flat at $2.6 billion and grew 5% on a constant currency organic basis (see Non-GAAP Financial Measures).

  • GlobeNewswire4 months ago

    STERIS to Announce Fiscal 2018 Fourth Quarter and Full Year Financial Results on May 9, 2018

    DERBY, U.K.  - April 25, 2018- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2018 fourth quarter and full ...